Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Eli Lilly (NY:LLY)

1,062.19 +34.68 (+3.38%)
Official Closing Price Updated: 4:00 PM EST, Dec 15, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Eli Lilly

< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
99 100 Next >
News headline image
Lilly's Oncology Momentum Soars: Olomorasib Gains Breakthrough Status, Jaypirca Achieves Landmark Clinical Successes
Eli Lilly and Company (NYSE: LLY) is making significant waves in the oncology landscape with a series of major announcements concerning two of its innovative cancer therapies: Olomorasib and Jaypirca... 
Via MarketMinute
News headline image
This Unstoppable Healthcare Stock Just Made a Move in AI: Time to Buy? ↗
Eli Lilly's initiative could make the company even more successful than it already is. 
Via The Motley Fool
Topics Artificial Intelligence
News headline image
Where Will Eli Lilly Be in 3 Years? ↗
With a market cap of $708 billion, Eli Lilly isn't far from becoming the first trillion-dollar healthcare company. 
Via The Motley Fool
News headline image
Peering Into Eli Lilly's Recent Short Interest ↗
 
Via Benzinga
Eli Lilly Says Its Obesity Pill Topped Novo Nordisk’s Oral Drug In Late-Stage Diabetes Trial ↗
Via Stocktwits
Why Is Eli Lilly’s Stock Slipping Premarket? ↗
Via Stocktwits
News headline image
Why Shares in Novo Nordisk Soared This Week ↗
Positive results from the trial further indicate that the company is poised to win the next battle in the weight loss drug market. 
Via The Motley Fool
News headline image
Prediction: Viking Therapeutics Stock Will Double in Value Within the Next 12 Months ↗
Viking's stock took a beating last month, and it has opened up a glorious buying opportunity for investors. 
Via The Motley Fool
Topics Bankruptcy
News headline image
Eli Lilly’s Oral GLP-1 Breakthrough Could Change Everything ↗
Eli Lilly stock rises on FDA fast-track hopes for its oral GLP-1 obesity drug and $27B U.S. manufacturing expansion; it's a tough trade but solid long-term hold 
Via MarketBeat
News headline image
My Top Biotech Stock Picks And Portfolio Strategy For The Next 3-10 Years ↗
Forecasts in biotech market indicate that by 2030, gene therapy will become more accessible, potentially generating hundreds of billions dollars in revenue. 
Via Benzinga
News headline image
Here's Why Novo Nordisk and Eli Lilly Could Still Be Absurdly Underrated Stocks to Buy Today ↗
Medicare and Medicaid coverage of GLP-1 weight loss drugs could be just what the doctor ordered for these two struggling stocks. 
Via The Motley Fool
Topics Government
News headline image
Hims & Hers, Eli Lilly, Novo Nordisk Face FDA Scrutiny: What It Means For Weight-Loss ETFs ↗
The FDA's warnings to Eli Lilly, Novo Nordisk and Hims & Hers spotlight risks for ETFs tied to the weight-loss drug boom. 
Via Benzinga
Topics ETFs
News headline image
Novo Nordisk Pops 8% On 'Significant' Weight Loss For Oral Wegovy ↗
Novo Nordisk stock surged Thursday after its oral version of Wegovy helped patients lose a "significant" amount of weight. 
Via Investor's Business Daily
News headline image
Novo Nordisk's Wegovy Outperforms Eli Lilly's Tirzepatide In Reducing Risk Of Heart Attack, Stroke, And Death: Study ↗
Novo Nordisk's Wegovy cut cardiovascular risks more than tirzepatide in real-world data from patients with obesity and heart disease. 
Via Benzinga
News headline image
Why Is Everyone Talking About Novo Nordisk Stock? ↗
Competition in various directions is affecting the company's fastest-growing product. 
Via The Motley Fool
News headline image
3 Dividend Growth Stocks You Can Buy and Forget About ↗
These stocks have been raising their payouts for years and they're likely going to continue doing so for the foreseeable future. 
Via The Motley Fool
Topics Economy
News headline image
Krispy Kreme Jumps After Hours Following Kash Patel's Stake Reveal ↗
Krispy Kreme's stock rose 3.81% after hours on Wednesday, following FBI Director Kash Patel's testimony about his stock purchase, despite a 68.28% drop in 2025. 
Via Benzinga
News headline image
1 Mega-Cap Stock with Impressive Fundamentals and 2 We Question
"Too big to fail" is how we would describe the megacap stocks in this article today. While they will likely stand the test of time, it’s not all sunshine and rainbows as their scale can limit their... 
Via StockStory
Topics Artificial Intelligence
News headline image
Novo Nordisk Stock Jumps After-Hours On Wegovy Pill Breakthrough As Weight-Loss War With Eli Lilly Heats Up ↗
The Danish drugmaker has already filed the once-daily pill with U.S. regulators, aiming for the first FDA-approved oral GLP-1 treatment for obesity. 
Via Stocktwits
News headline image
FBI Director Kash Patel Bought 2 Stocks In 2025 — One's Already A Meme Favorite ↗
FBI Director Kash Patel was asked about two stocks he bought earlier this year by a member of Congress on Wednesday and gave a surprising answer. The transactions come as members of Congress are... 
Via Benzinga
News headline image
Why Novo Nordisk Stock Popped Today ↗
Novo Nordisk lost half its value over the past year. Is it cheap enough to buy now? 
Via The Motley Fool
News headline image
Congressional Trading Report: Rep. David Taylor Sold Over $2K In Alphabet Stock ↗
 
Via Benzinga
News headline image
GSK To Pour $30 Billion Into US R&D, Manufacturing Over Five Years ↗
GSK will invest $30 billion in U.S. R&D and manufacturing, including a new biologics factory, AI upgrades, and expanded drug and device capabilities. 
Via Benzinga
Topics Artificial Intelligence
News headline image
Could This Eli Lilly Oral Pill Be Key To Significant Weight Loss? ↗
Eli Lilly's orforglipron showed significant weight loss, improved blood sugar, and reduced inflammation in adults with obesity or overweight in a Phase 3 trial. 
Via Benzinga
News headline image
Apple To Rally More Than 28%? Here Are 10 Top Analyst Forecasts For Wednesday ↗
 
Via Benzinga
News headline image
This FedEx Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Wednesday ↗
 
Via Benzinga
News headline image
Dow Futures Stall Ahead Of Fed’s Interest Rate Decision Today: WDAY, MSFT, GOOGL, NVDA Among Stocks To Watch ↗
While Dow Jones futures were up 0.03% at the time of writing, the S&P 500 futures fell 0.07%. 
Via Stocktwits
Topics ETFs Economy Government
News headline image
GSK Stock Climbs After-Hours On $30B US Investment Pledge As Trump Pressures Big Pharma To Build In America ↗
The plan includes $1.2 billion for a new biologics factory in Upper Merion, Pennsylvania, along with AI upgrades and expanded drug production across existing U.S. sites. 
Via Stocktwits
Topics Artificial Intelligence Government World Trade
News headline image
Why Eli Lilly Stock Was a Winner Today ↗
A news article implied that the company might have an advantage in the weight loss drug race. 
Via The Motley Fool
News headline image
Novo Nordisk Navigates a GLP-1 Gold Rush: Soaring Obesity Drug Sales Clash with Revised Outlook Amidst Mounting Competition
Copenhagen, Denmark – Pharmaceutical giant Novo Nordisk (NYSE: NVO) has reported a robust second quarter for 2025, with impressive revenue and net income figures largely propelled by the formidable... 
Via MarketMinute
Topics Earnings Economy Intellectual Property
< Previous 1 2
...
17 18 19 20 21 22 23 24 25
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.